This has served as a platform for completed and ongoing clinical studies in osteogenesis imperfecta, hypophosphatasia, x-linked hypophosphatemic rickets, and steroid-induced osteoporosis.
Since her fellowship, Dr. DiMeglio has been working in clinical research with a focus on Type 1 diabetes prevention and treatments, including new technologies, and also in the area of therapies for metabolic bone disease.
Dr. DiMeglio directs Riley Hospital’s participation in several type 1 diabetes research networks and supervises a research staff includng nurses, research coordinators, and technicians.
My areas of interest in my clinical practice include metabolic bone and calcium disorders and type 1 diabetes treatment and prevention.
- Pediatric Musculoskeletal Disease
Research: Islet Function and Survival